Literature DB >> 8050527

Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites.

G I Sanchez1, W O Rogers, S Mellouk, S L Hoffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050527     DOI: 10.1006/expr.1994.1060

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  15 in total

1.  Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.

Authors:  R Wang; D L Doolan; Y Charoenvit; R C Hedstrom; M J Gardner; P Hobart; J Tine; M Sedegah; V Fallarme; J B Sacci; M Kaur; D M Klinman; S L Hoffman; W R Weiss
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 2.  The development of a multivalent DNA vaccine for malaria.

Authors:  R C Hedstrom; D L Doolan; R Wang; M J Gardner; A Kumar; M Sedegah; R A Gramzinski; J B Sacci; Y Charoenvit; W R Weiss; M Margalith; J A Norman; P Hobart; S L Hoffman
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development.

Authors:  Cláudia Sá E Cunha; Britta Nyboer; Kirsten Heiss; Margarida Sanches-Vaz; Diana Fontinha; Ellen Wiedtke; Dirk Grimm; Jude Marek Przyborski; Maria M Mota; Miguel Prudêncio; Ann-Kristin Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

4.  EXP1 is required for organisation of EXP2 in the intraerythrocytic malaria parasite vacuole.

Authors:  Timothy Nessel; John M Beck; Shima Rayatpisheh; Yasaman Jami-Alahmadi; James A Wohlschlegel; Daniel E Goldberg; Josh R Beck
Journal:  Cell Microbiol       Date:  2020-02-12       Impact factor: 3.715

5.  Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.

Authors:  M Aidoo; A Lalvani; S C Gilbert; J T Hu; P Daubersies; N Hurt; H C Whittle; P Druihle; A V Hill
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Immune response against the exp-1 protein of Plasmodium falciparum results in antibodies that cross-react with human T-cell lymphotropic virus type 1 proteins.

Authors:  K R Porter; J Aguiar; A Richards; B Sandjaya; H Ignatias; H Hadiputranto; R G Ridley; B Takacs; F S Wignall; S L Hoffman; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.

Authors:  B Wizel; R A Houghten; K C Parker; J E Coligan; P Church; D M Gordon; W R Ballou; S L Hoffman
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

8.  Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.

Authors:  Saidou Balam; Sope Olugbile; Catherine Servis; Mahamadou Diakité; Alba D'Alessandro; Geraldine Frank; Remy Moret; Issa Nebie; Marcel Tanner; Ingrid Felger; Thomas Smith; Andrey V Kajava; François Spertini; Giampietro Corradin
Journal:  Malar J       Date:  2014-12-19       Impact factor: 2.979

9.  Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.

Authors:  Joao C Aguiar; Jessica Bolton; Joyce Wanga; John B Sacci; Hideyuki Iriko; Julie K Mazeika; Eun-Taek Han; Keith Limbach; Noelle B Patterson; Martha Sedegah; Ann-Marie Cruz; Takafumi Tsuboi; Stephen L Hoffman; Daniel Carucci; Michael R Hollingdale; Eileen D Villasante; Thomas L Richie
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

10.  Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens.

Authors:  Brad C Stone; Arnold Kas; Zachary P Billman; Deborah H Fuller; James T Fuller; Jay Shendure; Sean C Murphy
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.